Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias

Leukemia

Volumn 13, Issue 11, 1999, Pages 1770-1775

  Brendel, C ^a   Mohr, B ^a   Schimmelpfennig, C ^a   Muller J ^a   Bornhauser M ^a   Schmidt, M ^a   Ritter, M ^a   Ehninger, G ^a   Neubauer, A ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

CD34; CD90; Cell sorting; FISH; Hematopoietic progenitor cells; Leukemia

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; THY 1 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CELL CLONE; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKOCYTE; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

EID: 0032745463     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401543     Document Type: Article

References (25)

1. Carella AM, Cunningham I, Lerma E, Dejana A, Benvenuto F, Podestà M, Celesti L, Chimirri F, Abate M, Vassalo F, Figari O, Parodi C, Sessarego M, Valbonesi M, Carlier P, Prencipe E, Gatti AM, Van Den Berg D, Hoffman R, Frassoni F. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol 1997; 15: 1575-1582.
2. Brugger W, Henschler R, Heimfeld S, Berenson R, Mertelsmann R, Kanz L. Positivly selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994; 84: 1421-1426.
3. Verfaille CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, MvGlave PB, BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myeloid leukemia patients. Blood 1996; 87: 4770-4779.
4. McNiece IK, Briddell R, Stoney G, Kern B, Zilm K, Recktenwald D, Miltenyi S. Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery. J Hematother 1997; 6: 5-11.
5. Grimwade D, Walker H, Oliver F, Wheathley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998; 92: 2322-2333.
6. Blair A, Hogge DE, Ailles LE, Lansdorp PM, Sutherland HJ. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 1997; 89: 3104-3112.
7. Ritter MA, Sauvage CA, Delio D. Human Thy-1 antigen: cell surface expression on early T and B lymphocytes. Immunology 1983; 49: 555-564.
8. Seeger RC, Danon YL, Rayner SA, Hoover H. Detection of a Thy1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with monoclonal antibody. J Immunol 1982; 128: 983-989.
9. Humeau L, Bardin F, Maroc C, Alario T, Galindo R, Mannoni P, Chabannon C. Phenotypic, molecular, and functional characterization of human peripheral blood CD34+/THY1+ cells. Blood 1996; 87: 949-955.
10. Murray L, Chen B, Galy A, Chen S, Tushinski R, Uchida N, Negrin R, Tricot G, Jagannath S, Vesole D, Barlogie D, Hoffmann R, Tsukamoto A. Enrichment of human hematopoietic progenitor stem cell activity in the CD34+Thy-1+Lin-subpopulation from mobilized peripheral blood. Blood 1995; 85: 368-378.
11. Bornhäuser M, Mohr B, Ehrenlechner U, Neubauer A, Ehninger G. Fluorescence in situ hybridization for the bcr/abl rearrangement is dependent on the percentage of nonlymphocytic cells in peripheral blood stem cell harvests. J Hematother 1998; 7: 425-430.
12. Inaba T, Shimazaki C, Sumikuma T, Takahashi R, Hirai H, Kikuta T, Sudo Y, Yamagata N, Ashihara E, Goto H, Fujita N, Yoshimura M, Nakagawa M. Flow cytometric analysis of Thy-1 expression in CD34-positive acute leukemia. Int J Hematol 1997; 66: 315-323.
13. Maguer-Satta V, Petzer AL, Eaves AC, Eaves CJ. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34 cells from patients with chronic myeloid leukemia. Blood 1996; 88: 1796-1804.
14. Petzer AL, Eaves CJ, Landsdorp PM, Ponchio L, Barnett MJ, Eaves AC. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 1996; 88: 2162-2171.
15. Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/makrophage. Am J Med 1977; 63: 125-130.
16. Martin PJ, Najfeld V, Hansen JA, Penfold GK, Jacobson RJ, Fialkow PJ. Involvement of the B-lymphoid system in chronic myelogenous leukemia. Nature 1980; 287: 49-50.
17. Saitoh K, Miura I, Takahashi N, Miura AB. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. Blood 1998; 92: 2886-2892.
18. Fogli M, Amabile M, Martinelli G, Fortuna A, Rondelli D, Ratta M, Curti A, Tura S, Lemoli RM. Selective expansion of normal hematopoietic progenitors from chronic myelogenous leukemia marrow. Br J Haematol 1998; 101: 119-129.
19. Peters R, Leyvraz S, Perey L. Apoptotic regulation in primitive hematopoietic precursors. Blood 1998; 92: 2041-2052.
20. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. Human bone marrow CD34-negative cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34-positive cells. Exp Hematol 1998; 26: 353-350.
21. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nature Med 1998; 4: 1038-1054.
22. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med 1998; 3: 1337-1345.
23. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-5012.
24. Miraglia S. Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90: 5013-5021.
25. De Waele M, Renmanns W, Damiaens S, Flament J, Schots R, Van Riet I. Different expression of adhesion molecules on myeloid and B-lymphoid CD34+ progenitors in normal bone marrow. Eur J Hematol 1997; 59: 277-286.